One additional newsworthy item for your list will be RenovoRX presentation of their phase 3 results next weekend. "We are pleased to present research supporting our TAMP therapy platform at the upcoming SIR 2024 conference, the largest professional gathering of interventional radiologists in North America,” said Shaun Bagai, CEO.
I know it’s not exactly IMU and yet it will potentially have a direct impact on a small part of our future trials.
IMU Price at posting:
11.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)